A study of 18F-FLT positron emission tomography/computed tomography imaging in cases of prefibrotic/early primary myelofibrosis and essential thrombocythemia
Mohamed A Yassin, Sadek A Nehmeh, Abdulqadir J Nashwan, Samah A Kohla, Shehab F Mohamed, Omar M Ismail, Ahmad Al Sabbagh, Firyal Ibrahim, Dina S Soliman, Lajos Szabados, Hadi Fayad, Mohamed A Yassin, Sadek A Nehmeh, Abdulqadir J Nashwan, Samah A Kohla, Shehab F Mohamed, Omar M Ismail, Ahmad Al Sabbagh, Firyal Ibrahim, Dina S Soliman, Lajos Szabados, Hadi Fayad
Abstract
The objectives of this research project are to study in patients with primary myelofibrosis (PMF) and Essential Thrombocythemia (ET); (1) the uptake patterns of FLT-PET (FLT-PET) and its value in diagnosing, staging, and treatment response monitoring of malignant hematopoiesis, (2) compare imaging findings from FLT-PET with bone marrow biopsy (standard of care), and (3) associate FLT-PET uptake patterns with genetic makeup such as JAK2 (Janus kinase 2), CALR (Calreticulin), MPL (myeloproliferative leukemia protein), Triple negative disease, and allele burden.This trial is registered in ClinicalTrials.gov with number NCT03116542. Protocol version: Mar 2017.
Conflict of interest statement
The authors have no conflicts of interests to disclose.
References
- Roh JL, Kim JS, Lee JH, et al. Utility of combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Oral Onco 2009;45:218–24.
- Andreoli A, Vercellino L, Ouvrier MJ, et al. Final results of a phase 1 study of 18F-FLT positron emission tomography (PET)/computed tomography imaging in myelofibrosis (FLT-MF-2009 study). 2014: 3195–3195.
- Agool A, Schot BW, Jager PL, et al. 18F-FLT PET in hematologic disorders: a novel technique to analyze the bone marrow compartment. J Nucl Med 2006;47:1592–8.
- Vercellino L, Ouvrier MJ, Barré E, et al. Assessing bone marrow activity in patients with myelofibrosis: results of a pilot study of 18F-FLT PET. J Nucl Med 2017;58:1603–8.
- Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016;127:2391–405.
- Turcotte E, Wiens LW, Grierson JR, et al. Toxicology evaluation of radiotracer doses of 3′-deoxy-3′-[18 F] fluorothymidine (18 F-FLT) for human PET imaging: laboratory analysis of serial blood samples and comparison to previously investigated therapeutic FLT doses. BMC Nucl Med 2007;7:1–9.
Source: PubMed